期刊文献+

磁共振在直肠癌术前分期中的应用 被引量:5

MRI in the preoperative staging of colorectal cancer applications
下载PDF
导出
摘要 目的:探讨磁共振(MRI)在直肠癌术前分期中的应用。方法:选取159例直肠癌患者进行磁共振检查,对直肠癌进行术前分期诊断,并将检查结果与术后病理检查结果比较。结果:MRI对直肠癌T1-2期、T3期、T4期及淋巴结转移诊断的敏感性为28.57%、94.51%、93.94%及88.54%,特异性为100.00%、58.82%、96.83%及50.79%,与病理检查分期诊断结果具有良好的一致性,差异具有统计学意义(P<0.05)。结论:MRI应用于直肠癌术前分期诊断具有较高的准确性,虽然目前尚处于初步阶段,但随着影像学技术不断提高,其诊断价值也会有进一步提升,值得临床应用。 Objective : To explore the MRI in the preoperative staging of colorectal cancer applications. Methods: 159 cases of colorectal cancer patients with MRI for preoperative staging of colorectal cancer , and the test results and the pathological examination results. Results : MRI for colorectal cancer T1-2 , T3 stage , T4 stage and lymph node metastasis had a sensitivity of 28.57% , 94.51% , 93.94% and 88.54% , specificity of 100.00% , 58. 82% , 96.83% and 50.79% with pathological staging showed good consistency , P 〈0.05, statistically significant difference. Conclusion: MRI used in preoperative staging of colorectal cancer with high diagnostic accuracy , al- though still at a preliminary stage , but with the imaging technology continues to improve , its diagnostic value will be further enhanced , worthy of promotion.
出处 《陕西医学杂志》 CAS 2013年第12期1613-1614,共2页 Shaanxi Medical Journal
关键词 直肠肿瘤 诊断 磁共振成像 肿瘤分期 Rectal neoplasms/diag nosis Magnetic resonance imaging Neoplasm staging
  • 相关文献

参考文献7

  • 1Davalos A,Toni D,Iweins F,et al.Neurological deterioration in acute ischemic stroke:potential predictors and associated factors in the European cooperative acute stroke study (ECASS)I.Stroke,1999,30:2631-2636.
  • 2王维治主编.神经病学.第5版.北京:人民卫生出版社,2004.135.
  • 3McLeod DS,Lefer DJ,Merges C,et al.Enhanced expression of intracellular adhesion molecule-1 and Pselectin in the diabetic human retina and choroid.Am J Pathol,1995,147:642-653.
  • 4Pandolfi A,Giaccari A,Cilli C,et al.Acute hyperglycemia and acute hyperinsulinemia decrease plasma fibrinolytic activity and increase plasminogen activator inhibitor type 1 in the rat.Acta Diabetol,2001,38:71-76.
  • 5Lees KR,Walters MR.Acute stroke and diabetes.Cerebrovasc Dis,2005,20:9-14.
  • 6Ding C,He Q,Li PA.Diabetes increases expression of ICAM after a brief period of cerebralischemia.JNeuroimmunol,2005,161:61-67.
  • 7钱进军,刘春风,赵康仁.脑梗死患者β纤维蛋白原-455G/A、-148C/T基因多态性和血浆纤维蛋白原水平研究[J].中风与神经疾病杂志,2004,21(2):147-149. 被引量:15

二级参考文献10

  • 1Ernst E,Resch KL.Fibrinogen as a cardiovascular risk factor:a meta-analysis and review of the literature[J].Ann Int Med,1993,118:956-963.
  • 2Nishinma S,Kario K,Ya Kushijink,et al.Genetic variation in the promoter region of the beta-fibrinogen gene is associated with ischemic stroke in a Japanese population[J].Blood Coagul Fibrinolysis,1998,9(4):373-379.
  • 3Green FR.Fibrinogen polymorphisms and atherothrombotic disease[J].Ann N Y Acad Sci,2001,936:549-559.
  • 4Humphries SE,Green FR,Temple A,et al.Genetic factors determining thrombosis and fibrinolysis[J].Ann Epidemiol,1992,2:371-385.
  • 5Schmidt H,Schmidt R,Niederkorn K,et al.Beta-fibrinogen gene polymorphism(C-148-T) is associated with carotid atherosclerosis:results of the Austrian stroke prevention study[J].Arterioscler Thromb Vasc Biol,1998,18(3):487-492.
  • 6Lacoviello L,Vischetti M,Zito F,et al.Genes encoding fibrinogen and cardicovascular risk[J].Hypertension,2001,38(5):1199-1203.
  • 7Tuut M,Hense HW.Smoking,other risk factors and fibrinogen levels evidence of effect modification[J].Ann Epidemiol,2001,11(4):232-238.
  • 8Anne TH,Birgit AL,Stere E,et al.A common mutation(G-455A) in the β-Fibrinogen promoter is an independent predictor of plasma fibrinogen,but not of ischemic heart disease[J].J Clin Invest,1997,99:3034-3039.
  • 9邝宇,蔡望伟,刘国勋,李凤芹,周代锋,蔡兰洁,周玉英,凌光鑫.海南黎族人β-纤维蛋白原基因-455G/A多态性的初步研究[J].中华医学遗传学杂志,2000,17(6):443-444. 被引量:19
  • 10马丽媛,赵勇,王兴宇,刘一仙,刘力生,Klaus Lindpaintner.纤维蛋白原基因G(-455)A多态性与缺血性脑卒中的关系[J].中华老年心脑血管病杂志,2001,3(2):96-98. 被引量:16

共引文献54

同被引文献55

  • 1白莉,陈雷,杨国志,等.MRI检查在直肠癌临床诊治中的应用[J]全科医生技能发展,2011,8(14):2825-2827.
  • 2Jemal A, Siegel R, Ward E, et al: Cancer statistics,2009 ~J~. CA Cancer J Ctin ,2009,59(4) :225-249.
  • 3Topova L, Hellmich G, Puffer E, et al,. Prognostic value of tumor response to neoadjuvant therapy in rec- tal carcinoma EJ~. Dis Colon Rectun~, 2011, 54 (4): 401-411.
  • 4Tiandra JJ, Kilkenny JW, Buie WD, et al: Practice parameters for the management of rectal cancer EJ~- Dis Colon Rectum ,2005,48(3) : 411-423.
  • 5Maas M, Lambregts DM, Lahaye MJ, et al: T-stag- ing of rectal cancer: accuracy of 3.0 Tesla MRI com- pared with 1.5 Tesla ~J~. Abdom Imaging, 2012,37 (3) :475-481.
  • 6Sebag-Montefiore D, Stephens RJ, Steele R, et al: Preoperative radiotherapy versus selective postopera- tive chemoradio-therapy in patients with rectal cancer (MRC CR07 and NCIC-CTGC016): a multicentre, ran- domised trial[-J~. Lancet, 2009,373 (9666) : 811-820.
  • 7Schlaberg R, Choe DJ, Brown KR, et al: XMRV is present in malignant prostatic epithelium and is associ- ated with prostate cancer, especially high-grade tumors [J~. Proc Natl Acad Sci USA,2009,106(38) : 16351- 16356.
  • 8Yamada I, Yoshino N, Tetsumura A, et aL: Colorectal carcinoma:local tumor staging and assessment of lymph node metastasis by high-resolution MR imaging in surgi- cal specimens[-J~. Int J Biomed Imaging, 2009,2009 : 659836.
  • 9Kehoe J,Khatri VP.Staging and prognsis of colon cancer[J].Surg Oncol Clin N Am,2006,15:129-146.
  • 10Vila JJ,Jiménez FJ,Irisarri R,et al.Rectal cancer staging with endoscopic ultrasonography:correlaion with pathological staging[J].Rev Esp Enferm Dig,2007,99:132-137.

引证文献5

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部